MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway
2020 · EBioMedicine · 96 citations
https://doi.org/10.1016/j.ebiom.2019.102609
Y
Yang Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
941
Citations
16
h-index
27
i10-index
Yang Zhou is an academic researcher from Jiangsu University. The author has contributed to research in topics: Radiomics and Machine Learning in Medical Imaging & Hepatocellular Carcinoma Treatment and Prognosis & MRI in cancer diagnosis. The author has an h-index of 16, co-authored 74 publications.
ORCID: 0000-0001-5296-220XPapers by this author
worksNuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer
2021 · Cancer Letters · 43 citations
https://doi.org/10.1016/j.canlet.2021.04.024
Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer
2020 · Oncogene · 42 citations
https://doi.org/10.1038/s41388-020-1384-3
SHAP based predictive modeling for 1 year all-cause readmission risk in elderly heart failure patients: feature selection and model interpretation
2024 · Scientific Reports · 40 citations
https://doi.org/10.1038/s41598-024-67844-7
The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer
2020 · BMC Cancer · 33 citations
https://doi.org/10.1186/s12885-020-06866-6
Immune inhibitory receptor LILRB2 is critical for the endometrial cancer progression
2018 · Biochemical and Biophysical Research Communications · 19 citations
https://doi.org/10.1016/j.bbrc.2018.09.114
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat